Author: Aran Singanayagam; Su-Ling Loo; Maria Calderazzo; Lydia J Finney; Maria-Belen Trujillo Torralbo; Eteri Bakhsoliani; Jason Girkin; Punnam Veerati; Prabuddha S Pathinayake; Kristy S Nichol; Andrew Reid; Joseph Foottit; Sebastian L Johnston; Nathan W Bartlett; Patrick Mallia
Title: Anti-microbial immunity is impaired in COPD patients with frequent exacerbations Document date: 2019_5_9
ID: 72jzqm86_1
Snippet: Chronic obstructive pulmonary disease (COPD) is an inflammatory airway disorder in which acute exacerbations represent a major complication. Acute exacerbations are a substantial cause of morbidity and mortality [1] [2] [3] and preventing exacerbations remains a major unmet need. There has been increasing interest in a recently identified sub-group of patients with COPD who are at risk of exacerbations, defined as the 'frequent exacerbator phenot.....
Document: Chronic obstructive pulmonary disease (COPD) is an inflammatory airway disorder in which acute exacerbations represent a major complication. Acute exacerbations are a substantial cause of morbidity and mortality [1] [2] [3] and preventing exacerbations remains a major unmet need. There has been increasing interest in a recently identified sub-group of patients with COPD who are at risk of exacerbations, defined as the 'frequent exacerbator phenotype'. 4 Patients with frequent exacerbations have worse clinical outcomes including increased morbidity 1 , accelerated lung function decline 2 and greater mortality 5 , suggesting that this group requires special consideration. To date, the underlying mechanisms that predispose such patients to more frequent exacerbations have not been elucidated. It is plausible that abnormalities in host immunity could underlie an increased propensity to exacerbations.
Search related documents:
Co phrase search for related documents- clinical outcome and exacerbation risk: 1, 2, 3, 4, 5, 6, 7, 8, 9
- clinical outcome and exacerbation risk COPD: 1, 2
- clinical outcome and host immunity: 1, 2, 3, 4
- clinical outcome and increase morbidity: 1, 2, 3, 4
- clinical outcome and interest increase: 1, 2
- clinical outcome and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- clinical outcome and major complication: 1, 2, 3, 4, 5
- clinical outcome and major unmet need: 1
- clinical outcome and mortality morbidity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- clinical outcome and obstructive pulmonary disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41
- clinical outcome and pulmonary disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67
- clinical outcome and recently identify: 1
- clinical outcome and special consideration: 1, 2
- clinical outcome and substantial cause: 1
- clinical outcome and unmet need: 1, 2, 3, 4
- COPD obstructive pulmonary disease and exacerbation prevent: 1, 2
- COPD obstructive pulmonary disease and exacerbation risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- COPD obstructive pulmonary disease and exacerbation risk COPD: 1, 2, 3, 4, 5, 6, 7
- COPD obstructive pulmonary disease and frequent exacerbation: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date